Period: September 7–11, 2026 Coverage: Traditional U.S. operating-company IPOs and consequential ECM...
Period: Week ended Friday, September 4, 2026 Coverage: Traditional U.S. operating-company IPOs of at...
Period: August 31–September 4, 2026 Coverage: Traditional U.S. operating-company IPOs and consequent...
Period: Week of August 24, 2026 Coverage: U.S. transactions of at least $100 million Bottom line. Th...
Lyntris Inc. (NYSE: LYNX) faced selling pressure from its first trade Wednesday, opening $2.00 below...
Lyntris Inc. (NYSE: LYNX) is preparing to raise approximately $492 million in an initial public offe...
The IPO market showed signs of its traditional late-summer slowdown Friday as Latigo Biotherapeutics...
Braveheart Bio (BRVE) Surges 66% in IPO Debut as Investors Embrace Precision Cardiovascular Medicine
Braveheart Bio, Inc. (NASDAQ: BRVE) delivered one of the strongest biotechnology IPO performances of...